Trial tests Extended-Release pill for blood fats
NCT ID NCT04079530
Summary
This study compared a new controlled-release version of the cholesterol drug pemafibrate to the standard version. It involved 60 adults with high triglycerides and other blood fat problems. The goal was to see if the new version worked as well, was safe, and how the body processed it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical Corporation Heishinkai OPHAC Hospital
Osaka, 532-0003, Japan
Conditions
Explore the condition pages connected to this study.